Table 2. Laboratory findings of patients with COVID-19 on admission in Fujian Province.
Normal range | All patients (n = 199) | |||
---|---|---|---|---|
Median (IQR) | Increased No (%) | Decreased No (%) | ||
Blood routine | ||||
White blood cell count, ×109/L | 3.5–9.5 | 5.03 (3.79–6.45) | 10 (5.0) | 40 (20.1) |
Neutrophil count, × 109/L | 1.8–6.3 | 3.24 (2.21–4.39) | 18 (9.0) | - |
Lymphocyte count, × 109/L | 1.1–3.2 | 1.28 (0.89–1.78) | - | 74 (37.2) |
Platelet count, × 109/L | 125.0–350.0 | 191 (156–238) | 9 (4.5) | 17 (8.5) |
Hemoglobin, g/L | 115–150 | 137 (126–149) | - | 14 (7.0) |
Blood biochemistry | ||||
Albumin g/L | 35.0–50.0 | .40.3 (36.8–44.3) | - | 26 (13.1) |
Total bilirubin, μmol/L | 3.0–22.0 | 12.9 (8.2–18.4) | 34 (17.1) | - |
Alanine aminotransferase, U/L | 9.0–52.0 | 24 (17–34) | 22 (11.1) | - |
Aspartate aminotransferase, U/L | 14.0–36.0 | 25 (20–32) | 47 (23.6) | - |
Lactate dehydrogenase, U/L | 140–350 | 225 (169–407) | 65 (32.7) | - |
Blood urea nitrogen, mmol/L | 2.5–6.1 | 3.7 (3.0–4.6) | 14 (7.0) | - |
Serum creatinine, μmol/L | 53.0–97.0 | 67 (55–79) | 16 (8.0) | - |
Creatine kinase, U/L | 38.0–174.0 | 65 (43–107) | 22 (11.1) | - |
Potassium, mmol/L | 3.5–5.1 | 3.9 (3.6–4.2) | 3 (1.5) | 33 (16.6) |
Sodium, mmol/L | 137.0–147.0 | 139 (136–140) | 2 (1.0) | 52 (26.1) |
Coagulation function (n = 170) | ||||
Prothrombin time | 10.5–13.5 | 11.8 (11.2–12.5) | 10 (5.0) | 13 (6.5) |
Activated partial thromboplastin time | 22.0–38.0 | 29.9 (27.3–33.7) | 17 (8.5) | 3 (1.5) |
Fibrinogen | 2.0–4.0 | 3.5 (3.0–4.3) | 53 (26.6) | 3 (1.5) |
D-dimer | 0–0.5 | 0.23 (0.05–0.38) | 29 (14.6) | - |
Blood gas analysis (n = 153) | ||||
pH | 7.35–7.45 | 7.42 (7.39–7.44) | 24 (12.1) | 4 (2.0) |
PaO2, mmHg | 83.0–108.0 | 95.6 (80.5–111.0) | - | 40 (20.1) |
SaO2, mmHg | 95.5–98 | 97.7 (96.1–98.2) | - | 27 (13.6) |
PaO2:FiO2, mmHg | >300 | 438 (342–512) | - | 27 (13.6) |
Infection-related biomarkers | ||||
Procalcitonin, ng/mL | 0–0.1 | 0.04 (0.03–0.06) | 27/187 | - |
C-reactive protein, mg/L | <10 | 6.74 (4.68–21.6) | 82/181 | - |
Nucleic acid positive for influenza B | - | 2 (0.02) | - | - |
IgM positive for influenza B | - | 3 (0.02) | - | - |
IgM positive for mycoplasma | - | 7 (0.04) | - | - |
The data are the median (IQR), n% or n/N. IQR = interquartile range, PaO2 = arterial oxygen pressure, SaO2 = arterial oxygen saturation, FiO2 = inspired oxygen fraction.